Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Berberis vulgaris extract for cutaneous leishmaniasis
IRCT2015060122512N1Phase 3Completed
- Sponsor
- Mashhad University of Medical Sciences
- Start
- Feb 2015
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of berberis vulgaris extract in cutaneous leishmaniasis (CL), sponsored by Mashhad University of Medical Sciences. Started Feb 2015; status: completed.
02
Drugs
berberis vulgaris extract
03
Conditions
cutaneous leishmaniasis (CL)
Beyond the preview
Go deeper on IRCT2015060122512N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT2015060122512N1.